Head and Neck Diseases by Alexandros G.Sfakianakis: Using a Surgical PSA-Threshold (> 0.2 ng/mL) to Define Biochemical Failure in the ASCENDE-RT Phase 3 Trial

Κυριακή 7 Μαΐου 2017

Using a Surgical PSA-Threshold (> 0.2 ng/mL) to Define Biochemical Failure in the ASCENDE-RT Phase 3 Trial

Publication date: May–June 2017
Source:Brachytherapy, Volume 16, Issue 3, Supplement
Author(s): William J. Morris, Mira Keyes, Tom Pickles

http://ift.tt/2pjHcMW

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Κυριακή 7 Μαΐου 2017

Using a Surgical PSA-Threshold (> 0.2 ng/mL) to Define Biochemical Failure in the ASCENDE-RT Phase 3 Trial

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου